DRUG
Price
$42.24
Change
-$1.71 (-3.89%)
Updated
Sep 5 closing price
Capitalization
325.43M
HURA
Price
$2.55
Change
+$0.02 (+0.79%)
Updated
Sep 5 closing price
Capitalization
127.62M
Interact to see
Advertisement

DRUG vs HURA

Header iconDRUG vs HURA Comparison
Open Charts DRUG vs HURABanner chart's image
Bright Minds Biosciences
Price$42.24
Change-$1.71 (-3.89%)
Volume$43.97K
Capitalization325.43M
TuHURA Biosciences
Price$2.55
Change+$0.02 (+0.79%)
Volume$208.72K
Capitalization127.62M
DRUG vs HURA Comparison Chart in %
Loading...
DRUG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DRUG vs. HURA commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DRUG is a Hold and HURA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (DRUG: $42.24 vs. HURA: $2.55)
Brand notoriety: DRUG and HURA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DRUG: 82% vs. HURA: 43%
Market capitalization -- DRUG: $325.43M vs. HURA: $127.62M
DRUG [@Biotechnology] is valued at $325.43M. HURA’s [@Biotechnology] market capitalization is $127.62M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DRUG’s FA Score shows that 0 FA rating(s) are green whileHURA’s FA Score has 0 green FA rating(s).

  • DRUG’s FA Score: 0 green, 5 red.
  • HURA’s FA Score: 0 green, 5 red.
According to our system of comparison, HURA is a better buy in the long-term than DRUG.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DRUG’s TA Score shows that 4 TA indicator(s) are bullish while HURA’s TA Score has 4 bullish TA indicator(s).

  • DRUG’s TA Score: 4 bullish, 4 bearish.
  • HURA’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, DRUG is a better buy in the short-term than HURA.

Price Growth

DRUG (@Biotechnology) experienced а +8.63% price change this week, while HURA (@Biotechnology) price change was -5.56% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.48%, and the average quarterly price growth was +31.71%.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DRUG($325M) has a higher market cap than HURA($128M). DRUG YTD gains are higher at: 17.268 vs. HURA (-37.653). DRUG has higher annual earnings (EBITDA): -8.94M vs. HURA (-25.16M). DRUG has more cash in the bank: 51.4M vs. HURA (8.51M). DRUG has less debt than HURA: DRUG (141K) vs HURA (559K). DRUG (0) and HURA (0) have equivalent revenues.
DRUGHURADRUG / HURA
Capitalization325M128M254%
EBITDA-8.94M-25.16M36%
Gain YTD17.268-37.653-46%
P/E RatioN/AN/A-
Revenue00-
Total Cash51.4M8.51M604%
Total Debt141K559K25%
FUNDAMENTALS RATINGS
HURA: Fundamental Ratings
HURA
OUTLOOK RATING
1..100
88
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DRUGHURA
RSI
ODDS (%)
Bearish Trend 1 day ago
76%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
88%
Momentum
ODDS (%)
Bullish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 20 days ago
84%
Declines
ODDS (%)
Bearish Trend 5 days ago
88%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
DRUG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TMAK9.50N/A
N/A
Touchmark Bancshares, Inc.
TRUHF0.14N/A
N/A
Truly International Holdings Ltd.
LABFF90.61N/A
N/A
LABORATORIOS FARMACEUTICOS ROVI SA
OMVKY13.45-0.16
-1.21%
OMV AG
OPWEF0.05N/A
-1.61%
Opawica Explorations Inc.

HURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, HURA has been loosely correlated with BIVI. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if HURA jumps, then BIVI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HURA
1D Price
Change %
HURA100%
+0.79%
BIVI - HURA
45%
Loosely correlated
+9.43%
CMND - HURA
37%
Loosely correlated
+0.93%
CMMB - HURA
31%
Poorly correlated
+1.31%
DRUG - HURA
29%
Poorly correlated
-3.89%
AMLX - HURA
29%
Poorly correlated
+2.51%
More